Concepedia

Laura Hix Glickman

LH

8

Publications

2.9K

Citations

8

H-Index

2015

Active since

Affiliations

Aduro BioTech (United States)(Current)

Sidney Kimmel Comprehensive Cancer Center

Johns Hopkins University

Genomics Institute of the Novartis Research Foundation

Tempest Technologies (United States)

Laura Hix Glickman is an author at Aduro BioTech (United States) specializing in tumor biology, cell biology, and medicine.

Top concepts

Publications per year

2015–2019

8

Publications

8

Direct Activation of STING in the Tumor Microenvironment Leads to Potent and Systemic Tumor Regression and Immunity

Leticia Corrales, Laura Hix Glickman, Sarah M. McWhirter et al. · Cell Reports · 2015 · 1.4K citations · Full text

STING agonist formulated cancer vaccines can cure established tumors resistant to PD-1 blockade

Juan Fu, David B. Kanne, Meredith L. Leong et al. · Science Translational Medicine · 2015 · 681 citations

Magnitude of Therapeutic STING Activation Determines CD8+ T Cell-Mediated Anti-tumor Immunity

Kelsey E. Sivick, Anthony L. Desbien, Laura Hix Glickman et al. · Cell Reports · 2018 · 417 citations · Full text

Combining STING-based neoantigen-targeted vaccine with checkpoint modulators enhances antitumor immunity in murine pancreatic cancer

Heather Kinkead, Alexander C. Hopkins, Eric R. Lutz et al. · JCI Insight · 2018 · 152 citations · Full text

NSG Mice Provide a Better Spontaneous Model of Breast Cancer Metastasis than Athymic (Nude) Mice

Madhavi Puchalapalli, Xianke Zeng, Liang Mu et al. · PLoS ONE · 2016 · 99 citations · Full text

, , +15

Rows per page

1–5 of 8